GlobeNewswire Inc.··The Rosen Law FirmImmutep's Failed Trial Triggers Stock Collapse as Rosen Law Firm Launches Securities Investigation
Immutep's failed Phase III trial triggered an 82.6% stock collapse, prompting a securities investigation by The Rosen Law Firm into potential shareholder claims.
IMMPinvestor lossessecurities class action